These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone. Marcus FI; Fontaine GH; Frank R; Grosgogeat Y Am Heart J; 1981 Apr; 101(4):480-93. PubMed ID: 7010975 [No Abstract] [Full Text] [Related]
5. [Amiodarone in the nineties: to whom and what dosage?]. Moro Serrano C; Hernández Madrid A; Lage Silveira J; Vivas Alvarez E; Kanjhi M Rev Esp Cardiol; 1995 Apr; 48(4):272-84. PubMed ID: 7740149 [No Abstract] [Full Text] [Related]
7. [Amiodarone and the thyroid gland: apropos of 2 cases of hypothyroidism]. Pucciarelli G; Caso P; Jacono A Clin Ter; 1978 Jan; 84(1):81-4. PubMed ID: 630815 [No Abstract] [Full Text] [Related]
8. Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Rosenbaum MB; Chiale PA; Ryba D; Elizari MV Am J Cardiol; 1974 Aug; 34(2):215-23. PubMed ID: 4843156 [No Abstract] [Full Text] [Related]
9. Effect of amiodarone on thyroid hormone economy. Posner J; Sobel RJ; Glick S Isr J Med Sci; 1984 Feb; 20(2):113-7. PubMed ID: 6423565 [TBL] [Abstract][Full Text] [Related]
10. [Action and adverse effects of amiodarone in Wolff-Parkinson-White syndrome]. Cosma C; Crepin D; Py J Nouv Presse Med; 1979 Mar; 8(11):865. PubMed ID: 450659 [No Abstract] [Full Text] [Related]
11. Effects of amiodarone studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia. Waleffe A; Bruninx P; Kulbertus HE J Electrocardiol; 1978 Jul; 11(3):253-60. PubMed ID: 308527 [No Abstract] [Full Text] [Related]
12. [Arrhythmias in Wolff-Parkinson-White syndrome]. Dabrowski A Kardiol Pol; 1976; 19(5):395-401. PubMed ID: 994367 [No Abstract] [Full Text] [Related]
13. Clinical use and pharmacology of amiodarone. Heger JJ; Prystowsky EN; Miles WM; Zipes DP Med Clin North Am; 1984 Sep; 68(5):1339-66. PubMed ID: 6387328 [TBL] [Abstract][Full Text] [Related]
14. [Electrocardiographic study of the action of amiodarone on intracardiac conduction in humans. Comparison between intravenous and oral administration (author's transl)]. Coutte R; Fontaine G; Frank R; Dragodanne C; Phan-Thuc H; Facquet J Ann Cardiol Angeiol (Paris); 1976 Dec; 25(6):543-8. PubMed ID: 1015783 [No Abstract] [Full Text] [Related]
15. Side effects during therapy with low dosage amiodarone. Landolina M; Beck Peccoz P; Piscitelli G; Maggioni AP; Volpi A; Galletti F; Tognoni G; Ferrario G; Giani P G Ital Cardiol; 1984 Sep; 14(9):723-6. PubMed ID: 6510626 [TBL] [Abstract][Full Text] [Related]
16. [Effect of intravenous amiodarone on electrophysiological characteristics of the human heart]. Drzewiecki J; Trusz-Gluza M; Kośmider J; Szcześniak S; Giec L Kardiol Pol; 1984; 27(1):45-54. PubMed ID: 6716757 [No Abstract] [Full Text] [Related]
17. [Study of the effect of amiodarone on thyroid function]. Bekaert J; Solvay H; Van Schepdael J Coeur Med Interne; 1979; 18(2):241-51. PubMed ID: 487716 [No Abstract] [Full Text] [Related]
18. Amiodarone: pharmacology and antiarrhythmic and adverse effects. Naccarelli GV; Rinkenberger RL; Dougherty AH; Giebel RA Pharmacotherapy; 1985; 5(6):298-313. PubMed ID: 2934688 [TBL] [Abstract][Full Text] [Related]
19. [Circulatory arrest after combined intravenous drugs for the treatment of orthodromic circular tachycardia of Wolff-Parkinson-White syndrome]. Gómez-Barrado JJ; García-Rubira JC; Turégano Albarrán S; Pavón García M; Hidalgo Urbano R; Montes Ramírez JM; Cruz Fernández JM Rev Esp Cardiol; 1997 Sep; 50(9):662-6. PubMed ID: 9380937 [TBL] [Abstract][Full Text] [Related]
20. Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias. Ward DE; Camm AJ; Spurrell RA Br Heart J; 1980 Jul; 44(1):91-5. PubMed ID: 7426166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]